MARATTO

article · International Journal of Health Sciences and Research

Diagnostic Precision of Immunoglobulin (IgM/IgG) and Rapid Antigen Tests in the Detection of COVID-19 in Port Harcourt, Rivers State

Abstract

An urgent diagnostic challenge is presented by the COVID-19 pandemic, particularly in resource-limiting settings. Numerous rapid antigen and antibody (IgM/IgG) tests are frequently used to diagnose COVID-19, but it is still unclear how accurate these tests are. With Real-Time Polymerase Chain Reaction (RT-PCR) serving as the gold standard approach for the detection of SARS-CoV-2. This comparative study was conducted to assess the diagnostic accuracy of the COVID-VIRO® Rapid antigen and COVID-PRESTO® rapid antibody (IgG/IgM) test kits. Nasopharyngeal swabs and capillary blood samples were obtained from 200 subjects suspected of being exposed to COVID-19. RT-PCR was used to detect the presence of SARS-CoV-2 in the nasopharyngeal swab specimens using the Magnetic Induction Cycler platform (MIC), the nasopharyngeal swabs were also assayed for the viral proteins using COVID-VIRO® rapid antigen test kits. IgM/IgG antibodies were detected in capillary blood samples using COVID-PRESTO® Rapid antibody test kits. The MIC qPCR cycler nCov assay's sensitivity and specificity were compared to those of the rapid test kits. Out of 200 samples, RT-PCR detected 90 as positive and 110 as negative. The sensitivity and specificity of the rapid antigen test were 95.5% and 100%, respectively. IgM rapid antibody test sensitivity and specificity were 38.9% and 90%, respectively, while IgG antibody test sensitivity and specificity were 40.7% and 82.6%, respectively. The findings from the investigation indicate that the rapid antigen test kit is more suitable than the rapid antibody (IgG/IgM) test kits since it performed better and had a stronger association with the gold standard RT-PCR. It is also more sensitive, specific, and accurate. Key words: Coronavirus Disease 2019 (Covid-19), Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2), Polymerase Chain Reaction (PCR), Deoxyribonucleic Acid (DNA), Immunoglobulin (Ig), and Cycle Threshold (Ct)

Research topics

  • SARS-CoV-2 and COVID-19 Research
  • Immune responses and vaccinations
  • Virology and Viral Diseases

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.52403/ijhsr.20240228

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.